Inequality and Human Genetics
By Richard Hayes,
The New York Times
| 09. 16. 2008
[Letter to the editor]
David Frum correctly acknowledges that income inequality in the United States has been growing steadily and that the use of genetic technology by the affluent to enhance the "intelligence, health, beauty and strength" of their offspring would exacerbate this trend. But his suggestion that this challenge could be addressed by somehow ensuring that all have access to such technology is woefully misguided. The advent of these technologies would spark a techno-eugenic rat race impossible to constrain absent some system of authoritarian, allocative control. It would fundamentally change the way people regard their children and one another and undermine the integrity of the common human nature that sustains all human values, beliefs and institutions. The genetic modification of our children is a practice that conservatives and liberals alike should be able to agree poses far more risks than benefits, and should be taken off the table as an option.
Richard Hayes
Executive Director
Center for Genetics and Society
Oakland, Calif.
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...